Transsphenoidal surgery for Cushing's disease.

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70

Transsphenoidal surgery for Cushing disease: experience with 136 patients. Neurosurgery (2012) 1.44

The Treatment of Cushing's Disease. Endocr Rev (2015) 1.35

Postoperative testing to predict recurrent Cushing disease in children. J Clin Endocrinol Metab (2009) 1.11

Quality of life and other outcomes in children treated for Cushing syndrome. J Clin Endocrinol Metab (2013) 0.95

Successful control of Cushing's disease in the elderly with long term metyrapone. Postgrad Med J (1986) 0.83

Selective inferior petrosal sinus sampling without venous outflow diversion in the detection of a pituitary adenoma in Cushing's syndrome. Neuroradiology (2011) 0.78

Treating Cushing's disease. Br Med J (Clin Res Ed) (1988) 0.75

Transphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg (1969) 3.12

Results of treatment in 108 patients with Cushing's syndrome. N Engl J Med (1971) 1.69

The Cushing syndromes: changing views of diagnosis and treatment. Ann Intern Med (1979) 1.54

Cushing's disease. Selective trans-sphenoidal resection of pituitary microadenomas. N Engl J Med (1978) 1.48

The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med (1984) 1.36

Transsphenoidal microsurgical management of Cushing's disease. Report of 100 cases. J Neurosurg (1983) 1.28

Transsphenoidal removal of pituitary microadenoma in Cushing's disease. Mayo Clin Proc (1978) 1.25

Results of treating childhood Cushing's disease with pituitary irradiation. N Engl J Med (1977) 1.17

Growth hormone and cortisol responsiveness in Cushing's syndrome. Relation to a possible central nervous system etiology. Am J Med (1972) 1.08

Coexisting pituitary adenomas and partially empty sellas. J Neurosurg (1978) 1.05

Cushing's disease with cure by resection of a pituitary adenoma. Evidence against a primary hypothalamic defect. Am J Med (1974) 1.04

Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion. J Clin Endocrinol Metab (1982) 1.01

Selective venous sampling for ACTH in Cushing's syndrome: differentiation between Cushing disease and the ectopic ACTH syndrome. Ann Intern Med (1981) 0.98

Cushing's syndrome occurring with pituitary chromophobe tumors. Acta Endocrinol (Copenh) (1959) 0.96

A survey of results with transsphenoidal surgery in Cushing's disease. N Engl J Med (1983) 0.96

Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease. J Clin Endocrinol Metab (1981) 0.95

Cushing's syndrome in a patient with an empty sella turcica and a microadenoma of the adenohypophysis. Am J Med (1976) 0.88

Treatment of Cushing's disease in childhood and adolescence by transsphenoidal microadenomectomy. N Engl J Med (1984) 0.88

Hormone secretion by human somatotrophic, lactotrophic, and mixed pituitary adenomas in culture. J Clin Endocrinol Metab (1979) 0.88

Presidential address: XVII Canadian Congress of Neurological Sciences. Cushing's disease: 50 years later. Can J Neurol Sci (1982) 0.86

Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab (1983) 0.84

Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease. Am J Pathol (1982) 0.84

Pituitary Cushing's syndrome and Nelson's syndrome: diagnostic criteria, surgical therapy, and results. Surg Neurol (1981) 0.82

Pituitary function before and after transsphenoidal adenomectomy in patients with Cushing's disease. Acta Neurochir (Wien) (1982) 0.81

Corticotropin releasing factor stimulates ACTH release from human pituitary corticotropic tumour cells in culture. Lancet (1982) 0.80

Suppression of cortisol secretion by low-dose dexamethasone testing in Cushing's disease. Case report. J Neurosurg (1983) 0.78

Treatment of Cushing's disease in juveniles with interstitial pituitary irradiation. Clin Endocrinol (Oxf) (1979) 0.77

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70

Quantification of, visualization of, and compensation for brain shift using intraoperative magnetic resonance imaging. Neurosurgery (2000) 2.49

Intraoperative compensation for brain shift. Surg Neurol (2001) 2.47

Lymphocytic and granulomatous hypophysitis: experience with nine cases. Neurosurgery (1997) 2.37

Detection and prevention of the trigeminocardiac reflex during skull base surgery. Acta Neurochir (Wien) (2007) 2.28

Intraoperative identification of motor areas of the rhomboid fossa using direct stimulation. J Neurosurg (1993) 2.27

Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma. Cent Eur Neurosurg (2010) 2.24

Posterior fossa neurovascular anomalies in essential hypertension. Lancet (1994) 2.22

Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension. Lancet (1998) 2.21

Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab (1995) 2.00

Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study. Eur J Endocrinol (2007) 1.83

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg (1997) 1.74

Slow rhythmic oscillations of blood pressure, intracranial pressure, microcirculation, and cerebral oxygenation. Dynamic interrelation and time course in humans. Stroke (1996) 1.63

Difficult intubation in acromegalic patients: incidence and predictability. Anesthesiology (2000) 1.61

Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg (1999) 1.60

Neurovascular relationship at the trigeminal root entry zone in persistent idiopathic facial pain: findings from MRI 3D visualisation. J Neurol Neurosurg Psychiatry (2005) 1.54

DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours. Eur J Endocrinol (2011) 1.48

Magnetic brain source imaging of focal epileptic activity: a synopsis of 455 cases. Brain (2003) 1.45

Pericollicular surgical approaches to the rhomboid fossa. Part I. Anatomical basis. J Neurosurg (1997) 1.41

Elevated inferior petrosal sinus levels of PTHrP in a patient with Cushing's disease. Clin Endocrinol (Oxf) (2001) 1.40

Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia. Clin Endocrinol (Oxf) (1989) 1.40

Trigemino-cardiac reflex in humans initiated by peripheral stimulation during neurosurgical skull-base operations. Its first description. Acta Neurochir (Wien) (2008) 1.29

Intraoperative magnetic resonance imaging with the magnetom open scanner: concepts, neurosurgical indications, and procedures: a preliminary report. Neurosurgery (1998) 1.20

Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 1. Reliability of flow velocities in clinical management. Neurosurgery (1993) 1.20

Molecular imaging of brain tumors: a bridge between clinical and molecular medicine? Mol Imaging Biol (2007) 1.17

Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med (1984) 1.12

Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab (1988) 1.11

Intraoperative magnetic resonance imaging during transsphenoidal surgery. J Neurosurg (2001) 1.10

Somatostatin receptor expression in the thyroid demonstrated with 111In-octreotide scintigraphy. Nuklearmedizin (1995) 1.09

Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol Psychiatry (1987) 1.08

Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 2. Pulsatility indices: normal reference values and characteristics in subarachnoid hemorrhage. Neurosurgery (1993) 1.06

Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol (2008) 1.06

Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol (Oxf) (1999) 1.05

Immunopathology of primary hypophysitis: implications for pathogenesis. Am J Surg Pathol (2005) 1.04

Coil migration after endovascular coil occlusion of internal carotid artery pseudoaneurysms within the sphenoid sinus. Minim Invasive Neurosurg (2009) 1.04

Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol (1999) 1.04

Functional neuronavigation with magnetoencephalography: outcome in 50 patients with lesions around the motor cortex. J Neurosurg (1999) 1.04

Continuous electromyography monitoring of motor cranial nerves during cerebellopontine angle surgery. J Neurosurg (2000) 1.04

Adaptation of a hexapod-based robotic system for extended endoscope-assisted transsphenoidal skull base surgery. Minim Invasive Neurosurg (2004) 1.03

Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg (1999) 1.03

Intrasphenoidal encephaloceles--a clinical entity. Acta Neurochir (Wien) (1987) 1.03

Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta Neuropathol (2004) 1.02

Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity. Radiother Oncol (2000) 1.02

Diffusion tensor imaging and white matter tractography in patients with brainstem lesions. Acta Neurochir (Wien) (2007) 1.01

Octreotide exerts different effects in vivo and in vitro in Cushing's disease. Eur J Endocrinol (1994) 1.01

The endocrine spectrum of arachnoid cysts in childhood. Pediatr Neurosurg (1999) 1.01

Simultaneous estradiol and progesterone receptor analysis in meningiomas. Surg Neurol (1986) 1.01

Intraoperative magnetic resonance imaging combined with neuronavigation: a new concept. Neurosurgery (2001) 1.01

Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure (2007) 1.01

Factors influencing the application accuracy of neuronavigation systems. Stereotact Funct Neurosurg (2000) 1.01

Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. AJNR Am J Neuroradiol (2007) 1.01

Human chorionic gonadotrophin immunoactivity in cystic intracranial tumours. Clin Endocrinol (Oxf) (1995) 1.01

Temporal lobe microdysgenesis in epilepsy versus control brains. J Neuropathol Exp Neurol (1999) 0.97

Magnetoencephalography in extratemporal epilepsy. J Clin Neurophysiol (2000) 0.97

Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients. Acta Neurochir (Wien) (2004) 0.96

Are flash-evoked visual potentials useful for intraoperative monitoring of visual pathway function? Neurosurgery (1987) 0.95

Surgical management of acromegaly. Endocrinol Metab Clin North Am (1992) 0.95

Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg (1990) 0.95

Difference in functional outcome of ipsilateral tinnitus after intraoperative occurrence of the trigemino-cardiac reflex in surgery for vestibular schwannomas. Acta Neurochir (Wien) (2007) 0.95

Neuronavigation: concept, techniques and applications. Neurol India (2002) 0.95

The coexistence of pituitary adenomas and meningiomas: three case reports and a review of the literature. Br J Neurosurg (1989) 0.94

Intrasellar pituitary tissue pressure, tumour size and endocrine status--an international comparison in 107 patients. Br J Neurosurg (1994) 0.94

Delayed trigeminocardiac reflex induced by an intraorbital foreign body. Ophthalmologica (2006) 0.94

Surgical and electrophysiological observations during clipping of 134 aneurysms with evoked potential monitoring. Neurosurgery (1990) 0.94

Glioma surgery evaluated by intraoperative low-field magnetic resonance imaging. Acta Neurochir Suppl (2003) 0.93

Factors that limit the use of flash visual evoked potentials for surgical monitoring. Electroencephalogr Clin Neurophysiol (1988) 0.93

Intraoperative high-field MRI: anatomical and functional imaging. Acta Neurochir Suppl (2006) 0.93

Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg (1997) 0.93

Determination of the elasticity parameters of brain tissue with combined simulation and registration. Int J Med Robot (2005) 0.93

[Hyperprolactinemia. Pathophysiology, clinical significance, therapy]. Internist (Berl) (1977) 0.92

Serum procalcitonin monitoring for differential diagnosis of ventriculitis in adult intensive care patients. Intensive Care Med (2002) 0.92

An automated robotic approach with redundant navigation for minimal invasive extended transsphenoidal skull base surgery. Minim Invasive Neurosurg (2005) 0.92

Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury. Acta Neurochir Suppl (2010) 0.92

[Trigeminocardiac reflex in pituitary surgery. A prospective pilot study]. Nervenarzt (2008) 0.92

Neurophysiologic monitoring in posterior fossa surgery. II. BAEP-waves I and V and preservation of hearing. Acta Neurochir (Wien) (1989) 0.91

Transsphenoidal surgery of parasellar pituitary adenomas. Acta Neurochir (Wien) (1988) 0.91

Correlation of sensorimotor activation with functional magnetic resonance imaging and magnetoencephalography in presurgical functional imaging: a spatial analysis. Neuroimage (2001) 0.91

Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization. Virchows Arch A Pathol Anat Histopathol (1991) 0.91

Frameless stereotactic brain biopsy procedures using the Stealth Station: indications, accuracy and results. Zentralbl Neurochir (2003) 0.91

Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas. J Endocrinol (2012) 0.90

Visualization of the pyramidal tract in glioma surgery by integrating diffusion tensor imaging in functional neuronavigation. Zentralbl Neurochir (2005) 0.90

Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors. Neurosurgery (1993) 0.90

Magnetic source imaging combined with image-guided frameless stereotaxy: a new method in surgery around the motor strip. Neurosurgery (1997) 0.90